Aesthetic medical device company Cartessa Aesthetics reported on Monday that it has entered into an exclusive distribution agreement with Aesthetics Biomedical for the latter's Vivace RF Microneedling device along the US East Coast.

Launched in 2016, Aesthetics Biomedical's Vivace Fractional Microneedling device combines the benefits of microneedling with the skin-tightening effects of radiofrequency (RF) and does so at highly precise and deep layers of the skin. The robotic precision minimizes discomfort, eliminates downtime and creates an ideal skin canvas to administer post-treatment serums.

Since Cartessa's launch in early 2017, the Vivace has been a standout in the company's product portfolio.

With demand for microneedling continuing to grow, the sales of the Vivace device grew nearly 300 percent in 2017 and Vivace treatments were up 60% in Q4 alone. When compared with competitive devices, Vivace is the most powerful and technically comprehensive RF microneedling device available.